The European Medicines Agency (EMA), the European Union's drug regulator, has recommended the use of a booster dose of Moderna COVID-19 vaccine, Spikevax, for people over 18 years of age, APA reports citing EMA.
"EMA’s human medicines committee (CHMP) has concluded that a booster dose of the COVID-19 vaccine Spikevax (from Moderna) may be considered in people aged 18 years and above," the statement reads.
The third dose of Spikevax administered six to eight months after the second dose resulted in an increase in antibodies in adults whose antibody levels were waning, according to the regulator.
The side effects after the booster are similar to those that may occur after the second dose, the EMA noted.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
